Financial and Investment Analysts H-1B salary at GlaxoSmithKline LLC: $124,200 average ($124,200-$124,200 range). 100% approval rate.
GlaxoSmithKline LLC has filed 1 H-1B petition for the Financial and Investment Analysts role, offering an average compensation of $124k. The average offered salary of $124k is 47% above the prevailing wage for this occupation. Most positions are located in North Carolina (100%). The certification rate is 100%.
| Total Filings | 1 |
| Approval Rate | 100% |
| Average Salary | $124,200 |
| Median Salary | $124,200 |
| 25th Percentile | $124,200 |
| 75th Percentile | $124,200 |
| Minimum Salary | $124,200 |
| Maximum Salary | $124,200 |
100% of filings offer salaries above the prevailing wage, with an average premium of 46.9%. The average prevailing wage is $85k (based on 1 filings with prevailing wage data).
Average processing time is 8 days (median: 8 days). Fastest: 8 days, slowest: 8 days. Based on 1 filings.
0% of filings are for new positions, while 0% are for continued employment (1 filings with data).
Average contract duration: 36 months (median: 36 months), based on 1 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 1 |
| State | Filings |
|---|---|
| North Carolina | 1 |
GlaxoSmithKline LLC has 1 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at GlaxoSmithKline LLC is $124,200, with a median of $124,200. Salaries range from $124,200 to $124,200.
The H-1B approval rate for Financial and Investment Analysts positions at GlaxoSmithKline LLC is 100% based on 1 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.